Recombinant Zoster vaccine (Jiangsu Recbio Technology )

重组带状疱疹疫苗(CHO细胞,瑞科生物)

Report date: 2026/05/13 20:02:10

Base Information

Drug NameRecombinant Zoster vaccine (Jiangsu Recbio Technology )
Drug Alias NameNovel adjuvanted recombinant shingles vaccine (BFA01)新佐剂重组带状疱疹疫苗(BFA01佐剂)REC-610
ClassificationVaccines > Development/production technology > Genetically engineered subunit vaccineVaccines > Application > Prophylactic vaccineVaccines > Biological material > Viral vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsHerpes Zoster
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryPhilippinesMainland China
CombinationsNo
Global Highest StatusNDA/BLA
Highest Status in ChinaNDA/BLA
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsHerpes Zoster
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A